Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Sahil Adriouch

12PUBLICATIONS
57CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

Sort by Publication Date:
|Apr 20, 2026
Methodological guidelines for P2X receptor assays and data interpretation.

|Nov 10, 2025
Adeno-associated viral vectors encoding anti-P2X7 nanobodies reduce graft-versus-host disease in a humanised mouse model.

Amal Elhage, Janna H Hadaya, Chloe Sligar

|Jan 11, 2024
Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice.

Catalina Abad, Mélanie Demeules, Charlotte Guillou

|Sep 06, 2023
Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors.

Helena Costa-Verdera, Carmen Unzu, Erika Valeri

|May 13, 2023
Animal Models for the Investigation of P2X7 Receptors.

Ronald Sluyter, Sahil Adriouch, Stephen J Fuller

|Feb 11, 2023
The Angiogenesis Inhibitor Isthmin-1 (ISM1) Is Overexpressed in Experimental Models of Glomerulopathy and Impairs the Viability of Podocytes.

Virgilia Sahiri, Jonathan Caron, Elena Roger

Pageof 2

Frequent Collaborators

3 joint publications

Pablo Pelegrin

3 joint publications

Ronald Sluyter

2 joint publications

Valérie Vouret-Craviari

1 joint publications

Mario Leutert

1 joint publications

Anna Salvetti

1 joint publications

Carlos de Torre-Minguela

1 joint publications

Carlos M Martínez

1 joint publications

Ada González-Lisorge

1 joint publications

Alexei Verkhratsky

1 joint publications

Christophe Duranton

Frequent Collaborators

3 joint publications

Pablo Pelegrin

3 joint publications

Ronald Sluyter

2 joint publications

Valérie Vouret-Craviari

1 joint publications

Mario Leutert

Top Related Videos

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels
16:36

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels

Published on : May 18, 2009

14.0K
A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research
08:17

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

15.3K
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

1.9K
See more related videos

Top Related Videos

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels
16:36

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels

Published on : May 18, 2009

14.0K
A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research
08:17

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

15.3K
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

1.9K
See more related videos